We conclude that MM survivors who achieve disease control after AHCT have excellent recovery of FACT-BMT and subscale scores to population norms by 1...
Given the important role trust plays in shared decision-making, clinicians working with MM patients should prioritize establishing positive, trusting...
The magnitude of OS benefit with upfront HDT is cytogenetics-dependent. Patients with high-risk cytogenetics should preferably receive upfront rather...
I risultati suggeriscono la potenziale utilità dell’analisi del cfDNA nel plasma del sangue periferico dei pazienti come biomarcatore rilevante per l...